Gynecologic Oncology Reports (Aug 2015)

The cost implications of the use of pegylated liposomal doxorubicin when choosing an anthracycline for the treatment of platinum-resistant ovarian cancer: A low-value intervention?

  • David E. Cohn,
  • William S. Shimp

DOI
https://doi.org/10.1016/j.gore.2015.06.009
Journal volume & issue
Vol. 13, no. C
pp. 47 – 48

Abstract

Read online

No abstracts available.